Clinical Trial Update: Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating CBG131 CAR-T cell therapy targeting CLDN18.2 for advanced gastric and pancreatic cancer. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• CBG131 CAR-T cell therapy (CBG131 CAR-T)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Advanced Gastric and Pancreatic Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING